Cuvposa FDA Approved Drugs
CUVPOSA [GlycopyrrolateC19H28NO3Br]
RX
- 1mg/5ml (oral solution)
Merz PharmsJul 28, 2010
- Reduce chronic severe drooling (i.e., sialorrhea) in patients with neurologic conditions associated with problem drooling.
GLYCOPYRROLATE [GlycopyrrolateC19H28NO3Br]
RX
- 0.2mg/ml (injection injectable)
1.5mg (oral tablet)
1mg (oral tablet)
Amneal Pharms CoJun 15, 2017
Hikma FarmaceuticaSep 21, 2011
LuitpoldJul 23, 1986
Somerset Theraps LlcJun 23, 2017
Nexgen PharmaMar 12, 2012
Appco Pharma LlcJan 3, 2017
Aurolife Pharma LlcApr 15, 2013
Dr Reddys Labs LtdMar 21, 2008
Leading Pharma LlcSep 21, 2012
Natco Pharma LtdJun 20, 2016
Par PharmAug 31, 2006
Rising Pharms IncDec 29, 2008
Santos BiotechFeb 3, 2014
Sun Pharm Inds LtdAug 18, 2009
Vintage PharmsOct 19, 2011
Hikma FarmaceuticaSep 21, 2011
LuitpoldJul 23, 1986
Somerset Theraps LlcJun 23, 2017
Nexgen PharmaMar 12, 2012
Appco Pharma LlcJan 3, 2017
Aurolife Pharma LlcApr 15, 2013
Dr Reddys Labs LtdMar 21, 2008
Leading Pharma LlcSep 21, 2012
Natco Pharma LtdJun 20, 2016
Par PharmAug 31, 2006
Rising Pharms IncDec 29, 2008
Santos BiotechFeb 3, 2014
Sun Pharm Inds LtdAug 18, 2009
Vintage PharmsOct 19, 2011
ROBINUL [GlycopyrrolateC19H28NO3Br]
RX
- 1mg (oral tablet)
Casper Pharma LlcApproved Prior To Jan 1, 1982
ROBINUL FORTE [GlycopyrrolateC19H28NO3Br]
RX
- 2mg (oral tablet)
Casper Pharma LlcApproved Prior To Jan 1, 1982
SEEBRI [GlycopyrrolateC19H28NO3Br]
RX
- 15.6mcg/inh (inhalation powder)
Sunovion Pharms IncOct 29, 2015
- Long - term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (copd).
WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.